Articles From: UPDATE: CF Industries rises on merger talks; AstraZeneca, AbbVie fall to NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic Complications


2014/9/23
By Sue Chang and Ben Eisen, MarketWatch SAN FRANCISCO (MarketWatch) -- These are the stocks making notable moves in the stock market on Tuesday.
Sign-up for UPDATE: CF Industries rises on merger talks; AstraZeneca, AbbVie fall investment picks
2014/9/23
To meet forthcoming carbon emissions reduction targets, Illinois must preserve its existing nuclear energy facilities, Exelon Senior Vice President of Federal Regulatory Affairs and Wholesale Market Policy Kathleen Barrón said today at a policy session convened by the Illinois Commerce Commission.
Sign-up for Exelon Stresses Critical Role of Illinois’ Nuclear Energy Facilities in Meeting Carbon Reduction Goals investment picks
2014/9/23
Deutsche Bank today announced that Lilian Camara has joined as Head of Client Development for Multinational Corporates, Latin America.
Sign-up for Deutsche Bank Strengthens Trade Finance and Cash Management for Corporates Group in Latin America investment picks
Celgene Corporation (NASDAQ: CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast), the Company’s oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Sign-up for Oral OTEZLA® (apremilast) Approved by the U.S. Food and Drug Administration for the Treatment of Patients with Moderate to Severe Plaque Psoriasis investment picks
2014/9/23
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Ikea will expand the sale of solar-panel systems to eight countries after nearly a year of selling them in the U.K. The Swedish home-furnishings company said Monday it will roll out the new products in the Netherlands next month, and in Switzerland later this year.
Sign-up for Solar panels may be coming to an Ikea near you investment picks
SALT LAKE CITY , Sept.
Sign-up for Zions Bancorporation Announces Pricing of Pending Any and All Tender Offer investment picks
By Eva Dou Alibaba's blockbuster $25 billion stock offering has made Jack Ma the wealthiest man in China, according to a new survey, as investor enthusiasm for Chinese technology names enriches a new generation of Internet moguls.
Sign-up for UPDATE: Alibaba's Jack Ma is China's richest person investment picks
Immersion Corporation (NASDAQ:IMMR), the leading developer and licensor of touch feedback technology, today announced that the company has launched TouchSense ® Engage , its groundbreaking software solution for enhancing mobile video with tactile effects.
Sign-up for Immersion Launches Solution for Adding Haptics to Video and Ad Content investment picks
2014/9/23
Law enforcement agencies looking for a new way to securely transport prisoners between facilities have an innovative option to consider based on the all-new Ford Transit.
Sign-up for Only People Not Thrilled About Riding in All-New Ford Transit? Prisoners investment picks
2014/9/23
- Business leaders are well known in the community - Executives will support bank's business development efforts in the city - New members bring solid business expertise HOUSTON , Sept.
Sign-up for BBVA Compass welcomes four new members to its Atlanta advisory board investment picks
Pfizer Inc. (PFE) has contacted Actavis PLC (ACT) to indicate its interest in a potential acquisition, Bloomberg reported Tuesday, citing people with knowledge of the matter.
Sign-up for Pfizer Has Contacted Actavis About Potential Deal, Parties Not In Formal Talks -Bloomberg investment picks
Shares of Actavis Plc (ACT) rose more than 2% in afternoon trade Tuesday, after Bloomberg News reported that the company was approached by Pfizer Inc. (PFE) to discuss a possible deal.
Sign-up for Actavis shares rise on report of Pfizer approach investment picks
http://media.marketwire.com/attachments/200507/216773_Fulton.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146709&ProfileId=051205&sourceType=1 LANCASTER, PA --
Sign-up for Fulton Financial Corporation Announces Dates for Third Quarter 2014 Earnings Release and Webcast investment picks
2014/9/23
Propel Capital Corporation - Distributions Press Release Canada NewsWire TORONTO , Sept.
Sign-up for Propel Capital Corporation - Distributions Press Release investment picks
WASHINGTON, Sept.
Sign-up for CoStar Group Named One of the World's Most Innovative Growth Companies by Forbes investment picks
2014/9/23
By David Weidner, MarketWatch SAN FRANCISCO (MarketWatch) -- The U.S. Treasury Department temporarily took some of the air out of stocks of global companies based here and abroad when it unveiled curbs on so-called tax inversions Tuesday.
Sign-up for How tax-inversion rules may stall mergers investment picks
-More than 52,000 pieces of new and used equipment and accessories for sale- LOS ANGELES , Sept.
Sign-up for Over $9 Million at Cost of Musical Instruments and Related Accessories Available Through GA Global Partners investment picks
By Mike Esterl Soda giants Coca-Cola Co.
Sign-up for Soda producers set goals on U.S. beverage calories investment picks
Glatfelter (NYSE: GLT) announced today that its Board of Directors declared a $0.11 per share cash dividend on its outstanding common stock.
Sign-up for Glatfelter Declares Dividend of $0.11 on Common Stock investment picks
2014/9/23
DENVER , Sept.
Sign-up for BioFuel Makes Announcement Regarding Rights Offering investment picks
2014/9/23
By MarketWatch, MarketWatch SAN FRANCISCO (MarketWatch) -- Bed Bath & Beyond (BBY) is expected to report its latest quarterly results after the closing bell Tuesday.
Sign-up for Bed Bath & Beyond will report earnings after hours investment picks
CHAGRIN FALLS, Ohio , Sept.
Sign-up for EnzymeBioSystems Announces Progress with an Enzyme Compound investment picks
LOS ANGELES, Sept.
Sign-up for City National Corporation to Announce Third-Quarter 2014 Earnings investment picks
2014/9/23
Cascades Tissue Group introduces today its brand new towel and tissue dispensing system: Tandem ® +. Sleek, stylish and created for performance, Tandem+ (pron. Tandem Plus) is designed to be the perfect solution for facility managers looking to manage operating costs while providing employees, customers and other patrons of their restrooms experiences that reflect well on their businesses and show that they care.
Sign-up for Cascades Tissue Group Launches New Tandem+ Towel and Tissue Dispensing System investment picks
2014/9/23
PRINCETON JUNCTION, N.J., Sept.
Sign-up for MISTRAS Group Announces Conference Call to Discuss Fiscal 2015 First Quarter Results on October 8, 2014 investment picks
NEW BRUNSWICK, N.J. , Sept.
Sign-up for Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results investment picks
2014/9/23
By Sue Chang and Ben Eisen, MarketWatch SAN FRANCISCO (MarketWatch) -- These are the stocks making notable moves in the stock market on Tuesday.
Sign-up for UPDATE: CF Industries rises on merger talks; AstraZeneca, AbbVie fall investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N.
Sign-up for NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic Complications investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: UPDATE: CF Industries rises on merger talks; AstraZeneca, AbbVie fall to NeuroMetrix CEO to Present at 29th Annual Meeting of Japan Society of Diabetic Complications
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices